Protein alterations associated with temozolomide resistance in subclones of human glioblastoma cell lines
出版年份 2011 全文链接
标题
Protein alterations associated with temozolomide resistance in subclones of human glioblastoma cell lines
作者
关键词
-
出版物
JOURNAL OF NEURO-ONCOLOGY
Volume 107, Issue 1, Pages 89-100
出版商
Springer Nature
发表日期
2011-10-06
DOI
10.1007/s11060-011-0729-8
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Long-term In Vitro Treatment of Human Glioblastoma Cells with Temozolomide Increases Resistance In Vivo through Up-regulation of GLUT Transporter and Aldo-Keto Reductase Enzyme AKR1C Expression
- (2015) Benjamin Le Calvé et al. NEOPLASIA
- Cell Surface Tetraspanin CD9 Mediates Chemoresistance in Small Cell Lung Cancer
- (2010) S. Kohmo et al. CANCER RESEARCH
- TIP47 confers resistance to taxol-induced cell death by preventing the nuclear translocation of AIF and Endonuclease G
- (2010) Eniko Hocsak et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- TIP47 protects mitochondrial membrane integrity and inhibits oxidative-stress-induced cell death
- (2010) E. Hocsak et al. FEBS LETTERS
- Characterisation of a multimeric protein complex associated with ERp57 within the nucleus in paclitaxel-sensitive and -resistant epithelial ovarian cancer cells: The involvement of specific conformational states of β-actin
- (2010) Cicchillitti INTERNATIONAL JOURNAL OF ONCOLOGY
- Acquisition of Temozolomide Chemoresistance in Gliomas Leads to Remodeling of Mitochondrial Electron Transport Chain
- (2010) Claudia R. Oliva et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Comparative proteomic analysis of paclitaxel sensitive A549 lung adenocarcinoma cell line and its resistant counterpart A549-Taxol
- (2010) Qiang-ling Sun et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Proteomics of Hepatocellular Carcinoma: Serum Vimentin As a Surrogate Marker for Small Tumors (≤2 cm)
- (2010) Stella Sun et al. JOURNAL OF PROTEOME RESEARCH
- Chemo-Resistant Protein Expression Pattern of Glioblastoma Cells (A172) to Perillyl Alcohol
- (2010) Juliana de Saldanha da Gama Fischer et al. JOURNAL OF PROTEOME RESEARCH
- Glioma proteomics: Status and perspectives
- (2010) Simone P. Niclou et al. Journal of Proteomics
- Phosphorylated ezrin is located in the nucleus of the osteosarcoma cell
- (2010) Claudio Di Cristofano et al. MODERN PATHOLOGY
- Multiple roles of the cell cycle inhibitor p21CDKN1A in the DNA damage response
- (2010) Ornella Cazzalini et al. MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH
- Genomic and Molecular Profiling Predicts Response to Temozolomide in Melanoma
- (2009) C. K. Augustine et al. CLINICAL CANCER RESEARCH
- Peptide screening of cerebrospinal fluid in patients with glioblastoma multiforme
- (2009) M.U. Schuhmann et al. EJSO
- TIP47 functions in the biogenesis of lipid droplets
- (2009) Anna V. Bulankina et al. JOURNAL OF CELL BIOLOGY
- Circulating Lamin B1 (LMNB1) Biomarker Detects Early Stages of Liver Cancer in Patients
- (2009) Stella Sun et al. JOURNAL OF PROTEOME RESEARCH
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
- (2009) Roger Stupp et al. LANCET ONCOLOGY
- iTRAQ-based Proteomics Profiling Reveals Increased Metabolic Activity and Cellular Cross-talk in Angiogenic Compared with Invasive Glioblastoma Phenotype
- (2009) Uros Rajcevic et al. MOLECULAR & CELLULAR PROTEOMICS
- Biology of angiogenesis and invasion in glioma
- (2009) Matthew C. Tate et al. Neurotherapeutics
- Up-regulation of NG2 proteoglycan and interferon-induced transmembrane proteins 1 and 3 in mouse astrocytoma: A membrane proteomics approach
- (2008) Nicholas T. Seyfried et al. CANCER LETTERS
- Cathepsin D protects human neuroblastoma cells from doxorubicin-induced cell death
- (2008) Vitalia Sagulenko et al. CARCINOGENESIS
- Mismatch Repair Deficiency Does Not Mediate Clinical Resistance to Temozolomide in Malignant Glioma
- (2008) J. A. Maxwell et al. CLINICAL CANCER RESEARCH
- Serum 2-HS Glycoprotein Predicts Survival in Patients with Glioblastoma
- (2008) V. Petrik et al. CLINICAL CHEMISTRY
- Emerging drugs for malignant glioma
- (2008) Warren P Mason EXPERT OPINION ON EMERGING DRUGS
- Unique proteomic features induced by a potential antiglioma agent, Nordy (dl-nordihydroguaiaretic acid), in glioma cells
- (2008) Xiu-Wu Bian et al. PROTEOMICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started